{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:21:41Z","timestamp":1790612501197,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"DOI":"10.1007\/s00702-025-03066-z","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:37:33Z","timestamp":1763444253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of device-aided therapies on quality of life in patients with Parkinson\u2019s disease. A comparative multicenter observational study"],"prefix":"10.1007","author":[{"given":"Diego","family":"Santos-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Solleiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Gonz\u00e1lez-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"L\u00f3pez-Ariztegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Legarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Esther","family":"Rojas-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Peral-Quir\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iria","family":"Cabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Garc\u00eda-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"S\u00e1nchez-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Hern\u00e1ndez-Vara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bl\u00e1zquez-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"S\u00e1nchez-Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"DATs-PD GETM Spanish Registry Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Adarmes G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Alonso-Modino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"\u00c1lvarez Sauco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"\u00c1vila Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Belmonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bl\u00e1zquez-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Caballero S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Caballol Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Cabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Campo Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cantarero Duque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Carrillo Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Casas Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Casta\u00f1o Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Castellano Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Castrillo Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. M.","family":"Cerd\u00e1n Santacruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cores Bartolom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cost Foraster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cubo Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Delgado Ballestero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Escalante Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Escamilla Sevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fanjul Arbos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Feliz Feliz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Fern\u00e1ndez-Pajar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fern\u00e1ndez Revuelta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Fern\u00e1ndez Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Freire \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Gamo Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Garc\u00eda Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Garc\u00eda Herruzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Garc\u00eda-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Garc\u00eda R\u00faiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Garrote Espina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. P.","family":"Gil Villar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"G\u00f3mez Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"G\u00f3mez L\u00f3pez de San Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"G\u00f3mez Rapela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. V.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gonz\u00e1lez Ardura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gonz\u00e1lez-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Gonz\u00e1lez Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hern\u00e1ndez Javier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hern\u00e1ndez-Vara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jes\u00fas Maestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Legarda Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"L\u00f3pez-Ariztegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"L\u00f3pez Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"L\u00f3pez Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"L\u00f3pez Manzanares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"L\u00f3pez Vald\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Lorenzo","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Lorenzo Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Mac\u00edas Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. J.","family":"Madrid Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mart\u00ed Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mart\u00edn Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Mart\u00ednez Castrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mata \u00c1lvarez Santullano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"M\u00e9ndez Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mendoza Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mir Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mondrag\u00f3n Rezola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Monterde Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. I.","family":"Morales Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mu\u00f1oz Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Novo Ponte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ojeda Lepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pardina Vilella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Pare\u00e9s Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Paz Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Peral Quir\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"P\u00e9rez Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"P\u00e9rez Rangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Perona Moratalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Planas-Ballv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Prendes Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Quibus Requena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"R\u00e1bano Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rivero de Aguilar Pensado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rojas-P\u00e9rez Mar\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ribacoba D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Romero F\u00e1brega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ru\u00edz L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ru\u00edz Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Samaniego Vinueza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Eufrasio Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"S\u00e1nchez Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"S\u00e1nchez-Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"S\u00e1nchez Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sancho Saldana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Santos-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Solano Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Solleiro Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Su\u00e1rez San Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tabar Comellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Tijero Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"Valero Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vinagre Arag\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vivas Villacampa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Vives Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"3066_CR1","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s40120-023-00533-1","volume":"12","author":"J Aldred","year":"2023","unstructured":"Aldred J, Freire-Alvarez E, Amelin AV et al (2023) Continuous subcutaneous foslevodopa\/foscarbidopa in Parkinson\u2019s disease: safety and efficacy results from a 12-month, single-arm, open-label, phase 3 study. Neurol Ther 12:1937\u20131958","journal-title":"Neurol Ther"},{"key":"3066_CR2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00415-010-5793-z","volume":"258","author":"A Antonini","year":"2011","unstructured":"Antonini A, Isaias IU, Rodolfi G et al (2011) A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation. J Neurol 258:579\u2013585","journal-title":"J Neurol"},{"key":"3066_CR3","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1007\/s12325-021-01747-1","volume":"38","author":"A Antonini","year":"2021","unstructured":"Antonini A, Odin P, Pahwa R et al (2021) The long-term impact of Levodopa\/Carbidopa intestinal gel on \u2019off\u2019-time in patients with advanced Parkinson\u2019s disease: a systematic review. Adv Ther 38:2854\u20132890","journal-title":"Adv Ther"},{"key":"3066_CR4","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s40263-022-00963-9","volume":"36","author":"A Antonini","year":"2022","unstructured":"Antonini A, Pahwa R, Odin P et al (2022) Comparative effectiveness of device-aided therapies on quality of life and off-time in advanced Parkinson\u2019s disease: a systematic review and Bayesian network meta-analysis. CNS Drugs 36:1269\u20131283","journal-title":"CNS Drugs"},{"key":"3066_CR5","doi-asserted-by":"crossref","unstructured":"Blaabjerg M, Liang T, Peckham EL et al (2025) Improvement of troublesome dyskinesia in people with Parkinson\u2019s Disease treated with Foslevodopa\/Foscarbidopa (P7\u20135.032). Neurology 107(Suppl 1): 7.","DOI":"10.1212\/WNL.0000000000210696"},{"key":"3066_CR6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/mdc3.14018","volume":"11","author":"KR Chaudhuri","year":"2024","unstructured":"Chaudhuri KR, Facheris MF, Bergmans B et al (2024) Improved sleep correlates with improved quality of life and motor symptoms with foslevodopa\/foscarbidopa. Mov Disord Clin Pract 11:861\u2013866","journal-title":"Mov Disord Clin Pract"},{"key":"3066_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2025.100330","volume":"12","author":"KR Chaudhuri","year":"2025","unstructured":"Chaudhuri KR, Bouchard M, Freire-Alvarez E et al (2025) Post hoc exploratory analysis of the effect of foslevodopa\/foscarbidopa continuous subcutaneous infusion on nocturia in patients with Parkinson\u2019s disease. Clin Parkinsonism Relat Disord 12:100330","journal-title":"Clin Parkinsonism Relat Disord"},{"key":"3066_CR8","unstructured":"Cohen J (1977) Statistical Power Analysis for the Behavioral Sciences. Academic 8"},{"key":"3066_CR9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jval.2011.11.035","volume":"15","author":"NS Da Rocha","year":"2012","unstructured":"Da Rocha NS, Power MJ, Bushnell DM, Fleck MP (2012) The EUROHIS-QOL 8-item index: comparative psychometric properties to its parent WHOQOL-BREF. Value Health 15:449\u2013457","journal-title":"Value Health"},{"key":"3066_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/mds.27626","volume":"34","author":"HS Dafsari","year":"2019","unstructured":"Dafsari HS, Martinez-Martin P, Rizos A et al (2019) EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson\u2019s Disease Study Group. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson\u2019s disease. Mov Disord 34:353\u2013365","journal-title":"Mov Disord"},{"key":"3066_CR11","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa060281","volume":"355","author":"G Deuschl","year":"2006","unstructured":"Deuschl G, Schade-Brittinger C, Krack P et al (2006) German Parkinson Study Group, Neurostimulation Section. A randomized trial of deep-brain stimulation for Parkinson\u2019s disease. N Engl J Med 355:896\u2013908","journal-title":"N Engl J Med"},{"key":"3066_CR12","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/mds.29066","volume":"37","author":"G Deuschl","year":"2022","unstructured":"Deuschl G, Antonini A, Costa J et al (2022) European academy of neurology\/movement disorder society-european section guideline on the treatment of Parkinson\u2019s disease: I. Invasive therapies. Mov Disord 37:1360\u20131374","journal-title":"Mov Disord"},{"key":"3066_CR13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/0021-9681(86)90038-X","volume":"39","author":"RA Deyo","year":"1986","unstructured":"Deyo RA, Centor RM (1986) Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance. J Chronic Dis 39:897\u2013906","journal-title":"J Chronic Dis"},{"key":"3066_CR14","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00415-016-8106-3","volume":"263","author":"S Drapier","year":"2016","unstructured":"Drapier S, Eusebio A, Degos B et al (2016) Quality of life in Parkinson\u2019s disease improved by apomorphine pump: the OPTIPUMP cohort study. J Neurol 263:1111\u20131119","journal-title":"J Neurol"},{"key":"3066_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s40120-022-00435-8","volume":"12","author":"M Fabbri","year":"2023","unstructured":"Fabbri M, Barbosa R, Rascol O (2023) Off-time treatment options for Parkinson\u2019s disease. Neurol Ther 12:391\u2013424","journal-title":"Neurol Ther"},{"key":"3066_CR16","unstructured":"Fanhn S, Elton RL (1987) Members of the UPDRS development committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson's disease, Vol 2. Florham Park: Macmillan Health Care Information, pp 153\u2013164"},{"key":"3066_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","volume":"403","author":"T Foltynie","year":"2024","unstructured":"Foltynie T, Bruno V, Fox S, K\u00fchn AA, Lindop F, Lees AJ (2024) Medical, surgical, and physical treatments for Parkinson\u2019s disease. Lancet 403:305\u2013324","journal-title":"Lancet"},{"key":"3066_CR18","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1002\/mds.28703","volume":"36","author":"E Freire-Alvarez","year":"2021","unstructured":"Freire-Alvarez E, Kur\u010da E, Lopez Manzanares L et al (2021) Levodopa-carbidopa intestinal gel reduces dyskinesia in Parkinson\u2019s disease in a randomized trial. Mov Disord 36:2615\u20132623","journal-title":"Mov Disord"},{"key":"3066_CR19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40120-024-00583-z","volume":"13","author":"E Freire-Alvarez","year":"2024","unstructured":"Freire-Alvarez E, Vanni P, Kur\u010da E et al (2024) Dyskinesia and pain in advanced Parkinson\u2019s disease: post hoc analysis from the phase 3b, open-label, randomized DYSCOVER study. Neurol Ther 13:437\u2013447","journal-title":"Neurol Ther"},{"key":"3066_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195287","volume":"13","author":"M Haddad","year":"2018","unstructured":"Haddad M, Pud D, Treister R, Suzan E, Eisenberg E (2018) The effects of a dopamine agonist (apomorphine) on experimental and spontaneous pain in patients with chronic radicular pain: a randomized, double-blind, placebo-controlled, cross-over study. PLoS\u00a0One 13:e0195287","journal-title":"PLoS\u00a0One"},{"key":"3066_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/mds.23638","volume":"26","author":"RA Hauser","year":"2011","unstructured":"Hauser RA, Auinger P (2011) Parkinson Study Group. Determination of minimal clinically important change in early and advanced Parkinson\u2019s disease. Mov Disord 26:813\u2013818","journal-title":"Mov Disord"},{"key":"3066_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427\u2013442","journal-title":"Neurology"},{"key":"3066_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000455863","volume":"48","author":"K Horv\u00e1th","year":"2017","unstructured":"Horv\u00e1th K, Aschermann Z, Kov\u00e1cs M et al (2017) Changes in quality of life in Parkinson\u2019s disease: how large must they be to be relevant? Neuroepidemiology 48:1\u20138","journal-title":"Neuroepidemiology"},{"key":"3066_CR24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ageing\/26.5.353","volume":"26","author":"C Jenkinson","year":"1997","unstructured":"Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N (1997) The Parkinson\u2019s Disease Questionnaire (PDQ-39): development and validation of a Parkinson\u2019s disease summary index score. Age Ageing 26:353\u2013357","journal-title":"Age Ageing"},{"key":"3066_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1757","volume":"10","author":"WA Kamel","year":"2020","unstructured":"Kamel WA, Al-Hashel JY (2020) LCIG in treatment of non-motor symptoms in advanced Parkinson\u2019s disease: review of literature. Brain Behav 10:e01757","journal-title":"Brain Behav"},{"key":"3066_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.107905","author":"R Katzenschlager","year":"2025","unstructured":"Katzenschlager R, Bergquist F (2025) Continuous subcutaneous infusion therapies in Parkinson\u2019s disease: evidence of efficacy and safety. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107905. (Epub ahead of print)","journal-title":"Parkinsonism Relat Disord"},{"key":"3066_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.parkreldis.2020.12.024","volume":"83","author":"R Katzenschlager","year":"2021","unstructured":"Katzenschlager R, Poewe W, Rascol O et al (2021) Long-term safety and efficacy of apomorphine infusion in Parkinson\u2019s disease patients with persistent motor fluctuations: results of the open-label phase of the TOLEDO study. Parkinsonism Relat Disord 83:79\u201385","journal-title":"Parkinsonism Relat Disord"},{"key":"3066_CR28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.parkreldis.2019.11.008","volume":"69","author":"M Marano","year":"2019","unstructured":"Marano M, Naranian T, di Biase L et al (2019) Complex dyskinesias in Parkinson patients on levodopa\/carbidopa intestinal gel. Parkinsonism Relat Disord 69:140\u2013146","journal-title":"Parkinsonism Relat Disord"},{"key":"3066_CR29","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/mds.26067","volume":"30","author":"P Martinez-Martin","year":"2015","unstructured":"Martinez-Martin P, Reddy P, Katzenschlager R et al (2015) Euroinf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson\u2019s disease. Mov Disord 30:510\u2013516","journal-title":"Mov Disord"},{"issue":"4","key":"3066_CR30","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/mds.23524","volume":"26","author":"A Merola","year":"2011","unstructured":"Merola A, Zibetti M, Angrisano S, Rizzi L, Lanotte M, Lopiano L (2011) Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson\u2019s disease. Mov Disord 26(4):664\u2013670","journal-title":"Mov Disord"},{"key":"3066_CR31","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3233\/JPD-201978","volume":"10","author":"HR Moes","year":"2020","unstructured":"Moes HR, Groenendal-Laurensse JWMJ, Drent M, Tissingh G, van Laar T (2020) Predictors of time to discontinuation of Levodopa-Carbidopa intestinal gel infusion: a retrospective cohort study. J Parkinsons Dis 10:935\u2013944","journal-title":"J Parkinsons Dis"},{"key":"3066_CR32","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00702-023-02656-z","volume":"130","author":"HR Moes","year":"2023","unstructured":"Moes HR, Henriksen T, S\u0142awek J, Phokaewvarangkul O, Buskens E, van Laar T (2023) Tools and criteria to select patients with advanced Parkinson\u2019s disease for device-aided therapies: a narrative review. J Neural Transm 130:1359\u20131377","journal-title":"J Neural Transm"},{"key":"3066_CR33","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/mds.28599","volume":"36","author":"FAP Nijhuis","year":"2021","unstructured":"Nijhuis FAP, Esselink R, de Bie RMA et al (2021) Translating evidence to advanced Parkinson\u2019s disease patients: a systematic review and meta-analysis. Mov Disord 36:1293\u20131307","journal-title":"Mov Disord"},{"key":"3066_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s42466-021-00157-6","volume":"3","author":"D Nyholm","year":"2021","unstructured":"Nyholm D, Jost WH (2021) An updated calculator for determining levodopa-equivalent dose. Neurol Res Pract 3:58","journal-title":"Neurol Res Pract"},{"key":"3066_CR35","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s40120-024-00635-4","volume":"13","author":"K Poplawska-Domaszewicz","year":"2024","unstructured":"Poplawska-Domaszewicz K, Batzu L, Falup-Pecurariu C, Chaudhuri KR (2024) Subcutaneous levodopa: a new engine for the vintage molecule. Neurol Ther 13:1055\u20131068","journal-title":"Neurol Ther"},{"key":"3066_CR36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/17434440.2025.2499153","volume":"22","author":"K Pop\u0142awska-Domaszewicz","year":"2025","unstructured":"Pop\u0142awska-Domaszewicz K, Metta V, Odin P, Chaudhuri KR (2025) The device-aided intrajejunal delivery of levodopa-entacapone-carbidopa intestinal gel the treatment of Parkinson\u2019s disease: overview of efficacy and safety. Expert Rev Med Devices 22:533\u2013544","journal-title":"Expert Rev Med Devices"},{"key":"3066_CR37","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601","journal-title":"Mov Disord"},{"key":"3066_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-01093-x","volume":"11","author":"A Ramirez-Zamora","year":"2025","unstructured":"Ramirez-Zamora A, Okun MS, Kukreja P et al (2025) Parkinson\u2019s disease quality of life at 12 months comparing invasive device-aided therapy with oral treatment. NPJ Parkinsons Dis 11:235 (Epub ahead of print)","journal-title":"NPJ Parkinsons Dis"},{"key":"3066_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40035-022-00317-x","volume":"11","author":"S Rota","year":"2022","unstructured":"Rota S, Urso D, van Wamelen DJ et al (2022) Why do \u201cOFF\u201d periods still occur during continuous drug delivery in Parkinson\u2019s disease? Transl Neurodegener 11:43","journal-title":"Transl Neurodegener"},{"key":"3066_CR40","doi-asserted-by":"crossref","unstructured":"Rukavina K, Ebersbach G, Gruber D (2025) Foslevodopa\/Foscarbidopa continuous subcutaneous infusion in Parkinson's disease: real-world short-term data on tolerability, infusion rate adjustments and concomitant medication. Mov Disord Clin Pract (Epub ahead of Print)","DOI":"10.1002\/mdc3.70249"},{"key":"3066_CR41","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/mdc3.14056","volume":"11","author":"D Santos-Garc\u00eda","year":"2024","unstructured":"Santos-Garc\u00eda D, de Deus T, Cores C et al (2024) COPPADIS Study Group. Levodopa-induced dyskinesias are frequent and impact quality of life in Parkinson\u2019s disease: a 5-year follow-up study. Mov Disord Clin Pract 11:830\u2013849","journal-title":"Mov Disord Clin Pract"},{"key":"3066_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0316052","volume":"20","author":"D Santos-Garc\u00eda","year":"2025","unstructured":"Santos-Garc\u00eda D, Gonz\u00e1lez-Ortega G, S\u00e1nchez-Alonso P et al (2025b) GETM Spanish Registry Group. Device-aided therapies (DATs) in Parkinson\u2019s disease (PD). The DATs-PD GETM Spanish registry protocol study. PLoS\u00a0One 20:e0316052","journal-title":"PLoS\u00a0One"},{"key":"3066_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16535","volume":"32","author":"D Santos-Garc\u00eda","year":"2025","unstructured":"Santos-Garc\u00eda D, L\u00f3pez-Manzanares L, Muro I et al (2025c) Effectiveness and safety of levodopa-entacapone-carbidopa infusion in Parkinson disease: a real-world data study. Eur J Neurol 32:e16535","journal-title":"Eur J Neurol"},{"key":"3066_CR44","doi-asserted-by":"crossref","unstructured":"Santos-Garc\u00eda D, Solleiro \u00c1, Gonz\u00e1lez-Ortega G et al (2025a) DATs\u2010PD GETM Spanish Registry Group. Profile of people with Parkinson's disease treated with a device-aided therapy in Spain. A comparative multicenter observational study. Mov Disord Clin Pract (Epub ahead of print)","DOI":"10.1002\/mdc3.70239"},{"key":"3066_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.1190","volume":"12","author":"JP Savaryn","year":"2024","unstructured":"Savaryn JP, Smith RL, Rosebraugh M et al (2024) Metabolite profiling of foslevodopa\/foscarbidopa in plasma of healthy human participants by LC-HRMS indicates no major differences compared to administration of levodopa\/carbidopa intestinal gel. Pharmacol Res Perspect 12:e1190","journal-title":"Pharmacol Res Perspect"},{"key":"3066_CR46","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1205158","volume":"368","author":"WM Schuepbach","year":"2013","unstructured":"Schuepbach WM, Rau J, Knudsen K et al (2013) EARLYSTIM Study Group. Neurostimulation for Parkinson\u2019s disease with early motor complications. N Engl J Med 368:610\u2013622","journal-title":"N Engl J Med"},{"key":"3066_CR47","unstructured":"Schwab RS, England AC (1969) In third symposium on Parkinson's disease. E. And S. Livingstone: Edinburgh, pp 152\u2013157"},{"key":"3066_CR48","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S1474-4422(22)00400-8","volume":"21","author":"MJ Soileau","year":"2022","unstructured":"Soileau MJ, Aldred J, Budur K et al (2022) Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson\u2019s disease: a randomised, double-blind, active-controlled, phase 3 trial. Lancet Neurol 21:1099\u20131109","journal-title":"Lancet Neurol"},{"key":"3066_CR49","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1056\/NEJMra2401857","volume":"391","author":"CM Tanner","year":"2024","unstructured":"Tanner CM, Ostrem JL (2024) Parkinson\u2019s disease. N Engl J Med 391:442\u2013452","journal-title":"N Engl J Med"},{"key":"3066_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-025-00789-9","author":"M V\u00e9rin","year":"2025","unstructured":"V\u00e9rin M, Sesar \u00c1, Amlani B et al (2025) Licensed subcutaneous infusion therapies in advanced Parkinson\u2019s disease: an indirect treatment comparison and cost-minimisation analysis. Neurol Ther. https:\/\/doi.org\/10.1007\/s40120-025-00789-9. (Epub ahead of print)","journal-title":"Neurol Ther"},{"key":"3066_CR51","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s10072-021-05530-6","volume":"43","author":"Y Yang","year":"2022","unstructured":"Yang Y, Chen L, Yao J et al (2022) Early implementation of intended exercise improves quality of life in Parkinson\u2019s disease patients. Neurol Sci 43:1761\u20131767","journal-title":"Neurol Sci"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-03066-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-03066-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-03066-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T07:02:56Z","timestamp":1763449376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-03066-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":51,"alternative-id":["3066"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-03066-z","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The project is being conducted in accordance with the ICH Good Clinical Practice version 6 Revision 2 standard, the fundamental ethical principles established in the Declaration of Helsinki and the Oviedo Convention, as well as the Spanish legal requirements for biomedical research (Biomedical Research Law\u00a014\/2007). The Project has been approved on 02\/APR\/2024 by the IRB \u201c\n                      Comit\u00e9 de \u00c9tica de la Investigaci\u00f3n Cl\u00ednica de Galicia from Spain\n                      \u201d with code number 2024\/109. Written informed consents from all participants in this study were obtained. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. The protocol, statistical analysis plan and unidentified participant data will be available on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical compliance statement"}}]}}